Evidence map›Paper›PMID 27822370›Full record

ArticleMultidisciplinary respiratory medicine2016

Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up.

David B Price, Job F M van Boven, Lisa M Law, Alessandra Cifra, R Brett McQueen

Abstract read
In one paragraph

Article in Multidisciplinary respiratory medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David B PriceAcademic Primary Care, Division of Applied Health Sciences, Polwarth building, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD UK.
Job F M van BovenDepartment of General Practice, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Lisa M LawResearch in Real Life, 5 Coles Lane, Oakington, Cambridge, CB24 3BA UK.
Alessandra CifraResearch in Real Life, 5 Coles Lane, Oakington, Cambridge, CB24 3BA UK.
R Brett McQueenResearch in Real Life, 5 Coles Lane, Oakington, Cambridge, CB24 3BA UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the absence of randomisation, observational studies must take extra care to create treatment groups that are comparable in terms of key characteristics. Various matching methods exist which can create sound comparisons, minimising confounding where possible. A recent observational study by Dal Negro et al. carried out a cost analysis comparing two asthma medications. They report strong conclusions which favour one treatment over the other, however they include little discussion on the limitations of their study. The purpose of this letter is to comment on the weaknesses of the study design, including the level of matching used, and to urge readers to consider these issues alongside the interpretation of results.

Indexed as

Asthma outcomesMatched cohortObservational

Identifiers

PMID27822370
PMCPMC5090892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.